Clinical trial
Time-dependent ex Vivo Influence of Rivaroxaban on Point-of-care Devices
NCT01613443 is registered in ClinicalTrials.gov with Cardioangiologisches Centrum Bethanien as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Time-dependent ex Vivo Influence of Rivaroxaban on Point-of-care Devices
- Lead sponsor
- Cardioangiologisches Centrum Bethanien
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- August 31, 2013
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
effect of noac on poct